MetLife Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
+42,929
| New | +$275K | ﹤0.01% | 2008 |
|
|
2024
Q2 | – | Sell |
-13,768
| Closed | -$39.1K | – | 2881 |
|
|
2024
Q1 | $39.1K | Sell |
13,768
-12,944
| -48% | -$36.8K | ﹤0.01% | 2739 |
|
|
2023
Q4 | $393K | Hold |
26,712
| – | – | ﹤0.01% | 1828 |
|
|
2023
Q3 | $489K | Hold |
26,712
| – | – | ﹤0.01% | 1654 |
|
|
2023
Q2 | $576K | Hold |
26,712
| – | – | ﹤0.01% | 1597 |
|
|
2023
Q1 | $784K | Hold |
26,712
| – | – | 0.01% | 1363 |
|
|
2022
Q4 | $987K | Buy |
26,712
+7,251
| +37% | +$268K | 0.01% | 1219 |
|
|
2022
Q3 | $548K | Buy |
19,461
+12,676
| +187% | +$357K | ﹤0.01% | 1576 |
|
|
2022
Q2 | $131K | Hold |
6,785
| – | – | ﹤0.01% | 2579 |
|
|
2022
Q1 | $87.2K | Buy |
+6,785
| New | +$87.2K | ﹤0.01% | 2638 |
|